Clinical Trial Update: Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a neuroblastoma vaccine for high-risk neuroblastoma after chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Neuroblastoma vaccine

Snippet

Sponsor: Malcolm Brenner | Conditions: Neuroblastoma | Phase 1 | Status: COMPLETED